AZD2811: Clinical Trials

2 trials of AZD2811, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1

Follow AZD2811: new trials by email Literature Review of AZD2811 trials Research Report on AZD2811

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.
AZD2811, Azacitidine, Venetoclax - Acute Myeloid Leukaemia
Phase 1TerminatedAstraZeneca502017-07-312022-04-05
A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.
AZD2811 - Advanced Solid Tumours
Phase 1CompletedAstraZeneca722015-10-282020-05-01

Conditions studied

Leukemia, Myeloid, Acute (1)  ·  Small Cell Lung Carcinoma (1)

Sponsors

AstraZeneca (2)

Countries

United States (2)  ·  Australia (1)

Top investigators

Howard A. Burris, III, M.D. (1)  ·  Howard Burris, MD (1)

Results publications

PMID 36871042, PMID 41933194